Mettler-Toledo International Inc.·Healthcare

Mettler-Toledo International, Inc. (NYSE: MTD - Get Free Report) has earned an average recommendation of "Moderate Buy" from the thirteen research firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price

COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE: MTD) is a leading globa.

Aberdeen Group plc grew its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 16.0% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,756 shares of the medical instruments supplier's stock after buying an additional 2,862 shares during

Canoe Financial LP lessened its holdings in Mettler-Toledo International, Inc. (NYSE: MTD) by 4.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,864 shares of the medical instruments supplier's stock after selling 2,260 shares during the period.

Nordea Investment Management AB increased its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 11.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 157,457 shares of the medical instruments supplier's stock after buying an additional 16,777 shares during the period. Nordea

Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 7.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715 shares of the medical instruments supplier's stock after acquiring an additional 616 shares
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Healthcare
Medical - Diagnostics & Research
16,000
1997-11-14
1.44